A detailed history of First Turn Management, LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, First Turn Management, LLC holds 400,644 shares of TGTX stock, worth $13.5 Million. This represents 3.18% of its overall portfolio holdings.

Number of Shares
400,644
Holding current value
$13.5 Million
% of portfolio
3.18%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$27.67 - $42.99 $11.1 Million - $17.2 Million
400,644 New
400,644 $15.8 Billion

Others Institutions Holding TGTX

About TG THERAPEUTICS, INC.


  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.88B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track First Turn Management, LLC Portfolio

Follow First Turn Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Turn Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on First Turn Management, LLC with notifications on news.